Las Vegas, NV -- (SBWIRE) -- 02/04/2013 -- PennyStockParlay.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Acme Packet, Inc. (NASDAQ:APKT) shares soared 22.82% to $29.39 after Oracle Corp today said it has agreed to buy Acme Packet Inc for about $2 billion. The $29.25 per share offer represents a 22 percent premium to Acme Packet's Friday close on the Nasdaq. The deal value is based on the number of outstanding shares as of Dec 31.
Additionally, the company will unveil its latest earnings tomorrow, Monday, February 4, 2013. The average analyst estimate is for a loss of 5 cents per share, a spike from profit of 13 cents in the year-ago quarter.
Should Investors Buy APKT After The Recent Drop? Find Out Here
Rockwell Medical Inc (NASDAQ:RMTI) stock climbed 12.25% to $7.24 after the company today announced successful topline results from the PRIME clinical study of Soluble Ferric Pyrophosphate (SFP), its investigational iron-delivery drug currently in Phase 3 clinical studies for the treatment of iron deficiency in hemodialysis patients. The PRIME study demonstrated that regular administration of SFP-iron via dialysate reduced the usage of erythropoietin stimulating agents (ESAs) during hemodialysis by 37.1% while maintaining iron balance and maximizing iron delivery.
We Have A Free Trend Analysis on RMTI, Find Out Here
Sonus Networks, Inc. (NASDAQ:SONS) shares gained 15.35% to $2.63. The company announced that it will report financial results for the fourth quarter and full year 2012 after the close of the market on Thursday, February 28, 2013. Following the release, Sonus Networks will host a conference call with the financial community at 4:30 p.m. EST to discuss the results.
Get More latest News, Rumors and Updates On SONS Here
Peregrine Pharmaceuticals (NASDAQ:PPHM) shares climbed 4.24% to $2.21. The company, on Jan. 7, provided an update from its internal review of discrepancies from its Phase II randomized, double-blind placebo-controlled trial of bavituximab in second-line non-small cell lung cancer (NSCLC) in 121 patients.
How To Trade PPHM Now After The Recent Volatile Moves? Find Out Here
Concurrent Computer Corporation (NASDAQ:CCUR) shares jumped 4.54% to $7.83. The company, on Jan. 29, said second quarter revenue was $16.6 million compared with $16.4 million for the same period in fiscal 2012, and $15.0 million in the preceding quarter. The company reported net income of $673 thousand, or $0.08 per diluted share, in the second quarter of fiscal 2013, compared with a loss of $833 thousand, or $0.10 per diluted share, in the same period in fiscal 2012, and net income of $325 thousand, or $0.04 per diluted share, in the preceding quarter.
Don’t Forget To Get Your Free Trend Analysis Here
PennyStockParlay.com has been successful in bringing Stock Parlay members with top penny stock newsletter. Stock Parlay’s staff and penny stocks exploration methods have proved 100% accurate in finding the best penny stocks move in e-mail alerts. PennyStockParlay.com works all day and night to find the best penny stock picks portfolio through penny stock newsletter. PennyStockParlay.com has kept winning members with top penny stock newsletter.
The assembled information disseminated by PennyStockParlay.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. PennyStockParlay.com does expect that investors will buy and sell securities based on information assembled and presented in PennyStockParlay.com. Please always do due diligence; consult a financial advisor before buying or selling stocks.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)